Montreal, Canada

Gemin X Pharmaceuticals Canada Inc.

USPTO Granted Patents = 7

% Expired Patents = 100.0



Forward Citations = 11

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Giorgio Attardo (5 out of 19 patents)

silverMedal Elise Rioux (3 out of 10 patents)

bronzeMedal Jean-Francois Lavallee (3 out of 5 patents)

4.  Sasmita Tripathy (2 out of 9 patents)

5.  Pierre Beauparlant (2 out of 3 patents)

6.  Anne Roulston (2 out of 2 patents)

7.  Terrence W Doyle (2 out of 47 patents)

8.  Sasmita Triparthy (1 out of 1 patent)

9.  Gerson Gonzalez (1 out of 1 patent)

10.  Elisc Rioux (1 out of 1 patent)

11.  Terrance W Deyle (1 out of 1 patent)

12.  Roy A Johnson (1 out of 4 patents)

13.  Xavier Billot (5 patents)

14.  Kenza Dairi (0 patent)


7 patents:

Company Overview
Gemin X Pharmaceuticals Canada Inc. is a biopharmaceutical company focused on developing novel cancer therapeutics. The company's innovative research and development efforts aim to deliver cutting-edge treatments for various types of cancer. Gemin X Pharmaceuticals is committed to improving patients' lives through the advancement of oncology medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#152 in Montreal

#2,102 in Canada

Montreal, CA
Montreal, Canada
Forward Citations = 11

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gemin X Pharmaceuticals Canada Inc.. Retrieved from https://idiyas.com/company/gemin-x-pharmaceuticals-canada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…